Quick answer: There is no solid human evidence that astaxanthin improves kidney function, and no evidence it damages healthy kidneys either. The only human trial done in people with real kidney disease (transplant recipients, 12 mg a day for 12 months) found no measurable benefit on the markers it tracked, and it did not even test creatinine or eGFR. Most of the “astaxanthin protects the kidneys” claims trace back to rodent studies using toxic injury models, not people. If you already have reduced kidney function, talk to your nephrologist before adding any supplement, astaxanthin included.

Is Astaxanthin Good for Kidneys? What the Research Actually Shows

Short version: nobody has shown that astaxanthin is good for kidneys in a way you could act on. The most relevant human trial, the XANTHIN trial, gave 61 kidney transplant recipients either 12 mg of astaxanthin or a placebo every day for a full year and tracked arterial stiffness, oxidative stress, and inflammation markers. The result, published in the American Journal of Clinical Nutrition, was blunt: astaxanthin had no effect on any of the three primary outcomes. The researchers noted the measurements varied a lot between people, which likely made it harder to detect a small effect if one existed.

That is the closest thing we have to a direct answer, and it is a negative one. Nobody ran a trial asking “does astaxanthin change creatinine or eGFR in people with kidney disease,” which is a different, narrower question than the one XANTHIN answered. Until that trial exists, “is astaxanthin good for kidneys” does not have a yes answer, and it does not have a documented-harm answer either. It has a we do not know answer, dressed up by supplement marketing to sound more settled than it is.

What Creatinine and eGFR Actually Measure

Creatinine is a waste product made when muscle tissue breaks down, and healthy kidneys filter it out of the blood at a fairly steady rate. When kidney filtering slows down, creatinine builds up in the blood, so a blood test for creatinine is used, along with age and sex, to calculate an estimated glomerular filtration rate, or eGFR. The word “estimated” matters. eGFR is not a direct measurement of how the kidneys are working. It is a formula that infers filtering capacity from a blood marker that is also affected by things that have nothing to do with kidney health, including diet, muscle mass, recent exercise, pregnancy, and some medications, according to patient education materials from the National Kidney Foundation.

This is exactly why a single creatinine reading is a weak way to judge whether any supplement, food, or workout routine is “good for the kidneys.” A bodybuilder who just added muscle can see creatinine rise for reasons that have nothing to do with kidney damage. Someone who cut back on meat can see it drop. If you want to learn the background on astaxanthin itself before going further into the kidney-specific evidence, the complete astaxanthin supplement guide covers sourcing, absorption, and dosing in one place.

The One Human Trial Done in People With Real Kidney Disease

Most astaxanthin research is done in healthy volunteers or athletes. The XANTHIN trial is the exception, and it is worth understanding in detail because it is the only large, controlled human study in people whose kidneys were already a clinical concern. The trial was registered and described in a 2008 protocol paper in BMC Nephrology, which planned to enroll 66 kidney transplant recipients, stratified by which anti-rejection drug they were on, into a randomized, double-blind, placebo-controlled design running for one year at 12 mg of astaxanthin daily.

The completed trial, published eight years later, randomized 61 patients and measured three things: arterial stiffness (aortic pulse wave velocity), oxidative stress (plasma F2-isoprostanes), and inflammation (plasma pentraxin-3). None of the three moved in a way that separated astaxanthin from placebo. That is a real, negative result in a real population of people with compromised kidney function, and it deserves more attention than it gets in supplement marketing copy that cites astaxanthin’s antioxidant properties as if benefit were assumed.

Here is the part that matters most for anyone typing “astaxanthin creatinine levels” into Google: this trial, run in transplant patients specifically because their kidneys were a known variable, did not use creatinine or eGFR as an outcome at all. Nobody has published a controlled human trial that specifically tracked what astaxanthin does to creatinine or eGFR in people with reduced kidney function.

The briefing

One honest health-science email a week

Plain-English breakdowns of supplement trials, biomarkers, and what the evidence does and does not support. Written for people who want the caveats, not the hype.



Free. No spam, no selling your address, unsubscribe in one click.

Where the “Astaxanthin Protects the Kidneys” Claim Actually Comes From

The protective claim you see repeated across supplement blogs is real, but it comes from a different kind of study than most readers assume. A 2008 rat study in Food and Chemical Toxicology gave astaxanthin to rats before poisoning them with mercuric chloride, a known kidney toxin. Astaxanthin reduced markers of lipid and protein oxidation and blunted some of the tissue damage, but the study authors were explicit that it did not prevent the rise in plasma creatinine caused by the mercury. In other words, even in a rodent model built specifically to showcase astaxanthin’s antioxidant effects, it did not fully protect kidney filtering function on the one marker most people care about.

Separately, several rodent studies on diabetes-induced kidney damage (diabetic nephropathy) report that astaxanthin reduced markers of kidney stress in mice and rats given very high, chemically induced blood sugar. Those are legitimate findings worth follow-up, but a mouse with drug-induced diabetes getting a concentrated dose of astaxanthin is not the same claim as “astaxanthin is good for kidneys” in a human being taking a 4 to 12 mg capsule with breakfast. No human trial has replicated the diabetic-kidney finding.

The table below lines up what has actually been tested against what marketing pages imply has been tested.

Evidence Population What it measured What it found
XANTHIN trial (2016) 61 human kidney transplant recipients, 12 mg/day, 12 months Arterial stiffness, oxidative stress, inflammation No significant difference vs. placebo on any measure
Mercury toxicity study (2008) Rats poisoned with mercuric chloride Lipid/protein oxidation, plasma creatinine Reduced oxidative damage; did not prevent creatinine rise
Liver enzyme meta-analysis (2024) 196 humans across 5 RCTs, 6 to 12 mg/day, 4 to 48 weeks ALT, AST, GGT, ALP Small ALT increase; no effect on the other three enzymes. No equivalent pooled analysis exists yet for kidney markers.
Glucose metabolism trial (2021) 44 completed, healthy and prediabetic adults, 12 mg/day, 12 weeks Glucose, HbA1c, lipids, endothelial function Improved several metabolic markers; creatinine and kidney function were not reported

Astaxanthin and Kidney Stones: Is There Any Connection?

There is no published human research linking astaxanthin supplementation to kidney stone formation, and none linking it to kidney stone prevention. This is a case where the honest answer is genuinely “unstudied,” not “safe” or “risky.” Most kidney stones form from calcium oxalate, and astaxanthin capsules do not contain the oxalate or calcium loads that raise stone risk from foods like spinach or almonds. That is a reasonable mechanistic reason not to worry, but it is not the same as a trial proving no effect. If you have a personal or family history of kidney stones, mention any new supplement, astaxanthin included, to the clinician managing that condition.

Could Astaxanthin Skew Your Creatinine Test Results?

There is no evidence that astaxanthin itself raises or lowers creatinine readings the way, for example, creatine monohydrate or high-protein diets can. The confusion some people run into is a naming one: astaxanthin and creatine are different compounds, and creatine supplementation (not astaxanthin) is the well-documented cause of harmless creatinine elevation in bodybuilders, because creatine breaks down into creatinine as a normal byproduct. If your creatinine came back elevated and you take both astaxanthin and creatine, creatine is the far more likely explanation, and it is worth mentioning both supplements to whoever ordered the test so they can interpret the number correctly instead of assuming kidney damage from a single reading.

Who Should Be Cautious About Taking Astaxanthin

Astaxanthin is generally well tolerated in the doses studied, but “generally well tolerated in short trials of healthy people” is not the same statement as “safe for everyone with a kidney condition.” A few groups warrant a conversation with a clinician first:

  • Anyone with diagnosed chronic kidney disease, since no dedicated safety trial exists for this group specifically on kidney markers.
  • Kidney transplant recipients on immunosuppressants, since the XANTHIN trial population is the only one studied and it showed no benefit, not a safety concern, but also not a green light for higher doses than tested.
  • Anyone on blood pressure medication or blood sugar medication, since astaxanthin has measurable effects on both blood pressure and glucose markers in some trials, which could interact with dosing. The astaxanthin drug interactions guide covers this in more detail.
  • Anyone already told to limit certain antioxidant supplements by a nephrologist managing dialysis or advanced CKD.

For a fuller rundown of who should get medical clearance before starting, see who should not take astaxanthin, and for general tolerability data across trials, see the astaxanthin dangers breakdown, which separates documented effects from internet rumor.

How to Read “Best Astaxanthin for Kidneys” Reviews Without Getting Misled

Searches for “best astaxanthin for kidneys” and “astaxanthin reviews for kidneys” mostly return affiliate content, not clinical guidance, because no regulatory body approves an astaxanthin product for kidney support in the first place. Anything sold as a dietary supplement, including a specific branded product marketed for kidney support such as Clarity MD astaxanthin, is not FDA reviewed for that claim before it reaches shelves. That does not make a given product bad, but it means the label claim itself is marketing language, not a stamp of clinical evidence, and it applies equally to every brand making a kidney-specific pitch, not just one.

When you are comparing products, the label details that are actually verifiable are the source organism (Haematococcus pluvialis is the most studied), the milligram dose per serving, and whether a certificate of analysis is available for that batch. None of those details change the underlying research picture on kidneys described above. For a walkthrough of how to vet a product label line by line, see the guide to reading astaxanthin reviews.

What Would Change This Answer

The current picture is not a permanent verdict, it is a snapshot of thin evidence. A few specific things would move the needle:

  • A randomized trial that uses creatinine, cystatin C based eGFR, or a measured GFR (not estimated) as a primary outcome, run in people with stage 2 or 3 chronic kidney disease rather than transplant recipients.
  • A dose-response human study, since every human trial referenced here used a single dose of roughly 12 mg a day, leaving higher research doses (up to 24 mg in some trials for other outcomes) completely untested for kidney-specific markers.
  • Replication of the diabetic-kidney rodent findings in a human trial enrolling people with diabetic kidney disease, the population where the animal signal is strongest.

Until one of those exists, the honest position is that astaxanthin’s kidney story is built on one negative human trial in a narrow population, plus a handful of animal studies that used disease models far more severe than everyday supplement use represents.

Frequently Asked Questions

Is astaxanthin good for kidneys?

There is no human trial showing astaxanthin improves kidney function. The only controlled human trial done in people with kidney disease (transplant recipients, 12 mg daily for 12 months) found no benefit on the markers it measured, and it did not test creatinine or eGFR directly. The honest answer is that the benefit claim is unproven, not that it is disproven.

Does astaxanthin raise or lower creatinine levels?

No published human research shows astaxanthin changes creatinine levels in either direction. People sometimes confuse astaxanthin with creatine, a different supplement that is well known to raise creatinine harmlessly through normal muscle metabolism. If your creatinine test result is elevated, review your full supplement list, including creatine, with the ordering clinician rather than assuming it is the astaxanthin.

Can astaxanthin cause kidney damage?

No published human study has reported kidney damage from astaxanthin at studied doses of roughly 4 to 12 mg per day, including in the one-year trial in kidney transplant recipients. That trial found no harm and no benefit on the markers it tracked. The absence of a documented-harm signal is reassuring but is not the same as a large, long-term safety study, since the existing human evidence base is small.

What is the best astaxanthin for kidneys?

No astaxanthin product is clinically proven or FDA reviewed for kidney support, so “best for kidneys” is not a claim any legitimate brand can back with evidence, including products marketed under that pitch. If kidney health is your goal, the more useful comparison points are third-party testing, the source organism, and milligram dose per serving, not kidney-specific marketing language.

Is Clarity MD astaxanthin good for kidneys?

There is no independent published research on this specific branded product’s effect on kidney markers, and that is true of essentially every branded astaxanthin product on the market. The underlying research picture on astaxanthin and kidney function described in this article applies regardless of which brand’s capsule the astaxanthin comes in, since the ingredient, not the label, is what has or has not been studied.

Does astaxanthin help with kidney stones?

There is no published research linking astaxanthin to either causing or preventing kidney stones. Most kidney stones are calcium oxalate stones, and astaxanthin supplements do not carry the oxalate or calcium load that raises stone risk from certain foods, but that is a reasoning point, not a clinical trial result. Anyone with a stone history should still run new supplements by their doctor.

Should someone with chronic kidney disease take astaxanthin?

Anyone with diagnosed chronic kidney disease should talk to their nephrologist before starting astaxanthin, since no dedicated safety or efficacy trial exists for this specific population outside of kidney transplant recipients. This is a general caution based on an evidence gap, not a documented interaction or danger.

Why did the kidney transplant trial not test creatinine?

The XANTHIN trial’s researchers chose arterial stiffness, oxidative stress, and inflammation as their primary outcomes because those were considered the more clinically pressing cardiovascular risks in transplant recipients at the time the trial was designed. Kidney transplant recipients already have their transplanted kidney’s function monitored separately by their transplant team, which may be part of why creatinine was not chosen as a trial endpoint for this particular antioxidant study.

This article is for general information and does not replace medical advice. Astaxanthin is a dietary supplement, not a drug, and it is not approved to treat, prevent, or cure kidney disease or any other condition. If you have chronic kidney disease, are a transplant recipient, are pregnant or breastfeeding, or take prescription medication, talk to your doctor or nephrologist before starting astaxanthin or any new supplement.